These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections. Calvert MB; Jumde VR; Titz A Beilstein J Org Chem; 2018; 14():2607-2617. PubMed ID: 30410623 [TBL] [Abstract][Full Text] [Related]
3. The arsenal of pathogens and antivirulence therapeutic strategies for disarming them. Brannon JR; Hadjifrangiskou M Drug Des Devel Ther; 2016; 10():1795-806. PubMed ID: 27313446 [TBL] [Abstract][Full Text] [Related]
4. Antivirulence Strategies for the Treatment of Ford CA; Hurford IM; Cassat JE Front Microbiol; 2020; 11():632706. PubMed ID: 33519793 [No Abstract] [Full Text] [Related]
5. Green synthesis of silver nanoparticles using Carum copticum: Assessment of its quorum sensing and biofilm inhibitory potential against gram negative bacterial pathogens. Qais FA; Shafiq A; Ahmad I; Husain FM; Khan RA; Hassan I Microb Pathog; 2020 Jul; 144():104172. PubMed ID: 32224208 [TBL] [Abstract][Full Text] [Related]
7. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa. Hwang HJ; Choi H; Hong S; Moon HR; Lee JH Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853 [TBL] [Abstract][Full Text] [Related]
8. Antivirulence as a new antibacterial approach for chemotherapy. Escaich S Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647 [TBL] [Abstract][Full Text] [Related]
9. Bacterial genome engineering and synthetic biology: combating pathogens. Krishnamurthy M; Moore RT; Rajamani S; Panchal RG BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687 [TBL] [Abstract][Full Text] [Related]
10. Musa acuminata and its bioactive metabolite 5-Hydroxymethylfurfural mitigates quorum sensing (las and rhl) mediated biofilm and virulence production of nosocomial pathogen Pseudomonas aeruginosa in vitro. Vijayakumar K; Ramanathan T J Ethnopharmacol; 2020 Jan; 246():112242. PubMed ID: 31533077 [TBL] [Abstract][Full Text] [Related]
11. Inhibiting Type VI Secretion System Activity with a Biomimetic Peptide Designed To Target the Baseplate Wedge Complex. Cherrak Y; Filella-Merce I; Schmidt V; Byrne D; Sgoluppi V; Chaiaheloudjou R; Betzi S; Morelli X; Nilges M; Pellarin R; Durand E mBio; 2021 Aug; 12(4):e0134821. PubMed ID: 34372705 [TBL] [Abstract][Full Text] [Related]
12. Novel agents to inhibit microbial virulence and pathogenicity. Escaich S Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591 [TBL] [Abstract][Full Text] [Related]
13. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies. Law SKK; Tan HS Microbiol Res; 2022 Jul; 260():127032. PubMed ID: 35483311 [TBL] [Abstract][Full Text] [Related]
14. Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the D'Angelo F; Baldelli V; Halliday N; Pantalone P; Polticelli F; Fiscarelli E; Williams P; Visca P; Leoni L; Rampioni G Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201815 [TBL] [Abstract][Full Text] [Related]
15. Fatty Acids as Antibiofilm and Antivirulence Agents. Kumar P; Lee JH; Beyenal H; Lee J Trends Microbiol; 2020 Sep; 28(9):753-768. PubMed ID: 32359781 [TBL] [Abstract][Full Text] [Related]